Johnson & Johnson
JNJHealthcare·Drug Manufacturers - General·USA·Mega·NYSE·Nov 11 • 3:59 PM ET
Price
JNJ against its 20, 50 and 200-day averages1.0% under the 52-week high of 283.25 on 10 Nov 2026. 52-week low 189.05 on 11 Nov 2025. Last 15 sessions, 9.3% high to low
Volume 0.78× normal · the line is the 50-bar volume average
Profile
JNJJohnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.
| Index | DJIA, S&P 500, RUI |
|---|---|
| Employees | 140800 |
| IPO | Sep 25, 1944 |
| Beta | 0.20 |
| ATR, 14d | 6.93 |
| Rel volume | 0.78 |
| Short float | 0.71% |
| Insider own | 0.12% |
| Inst own | 77.48% |
Snapshot
6 groupsValuation
| Index | DJIA, S&P 500, RUI |
|---|---|
| Market Cap | 675.03B |
| Enterprise Value | 702.46B |
| Income | 16.09B |
| Sales | 99.35B |
| Book/sh | 33.87 |
| Cash/sh | 7.16 |
| Dividend Est. | 5.34 (1.91%) |
| Dividend TTM | 5.28 (1.88%) |
| Dividend Ex-Date | Nov 24, 2026 |
| Dividend Gr. 3/5Y | 4.92% 5.25% |
| Payout | 46.59% |
| Employees | 140800 |
| IPO | Sep 25, 1944 |
Ratios
| P/E | 42.54 |
|---|---|
| Forward P/E | 24.19 |
| PEG | 2.72 |
| P/S | 6.79 |
| P/B | 8.28 |
| P/C | 39.18 |
| P/FCF | 32.78 |
| EV/EBITDA | 20.80 |
| EV/Sales | 7.07 |
| Quick Ratio | 0.74 |
| Current Ratio | 1.02 |
| Debt/Eq | 0.55 |
| LT Debt/Eq | 0.44 |
| Option/Short | Yes / Yes |
Earnings
| EPS (ttm) | 6.59 |
|---|---|
| EPS next Y | 11.59 |
| EPS next Q | 2.91 |
| EPS this Y | 3.00% |
| EPS next Y | 4.31% |
| EPS next 5Y | 8.89% |
| EPS past 3/5Y | 17.88% 14.90% |
| Sales past 3/5Y | 5.56% 2.67% |
| EPS Y/Y TTM | -35.95% |
| Sales Y/Y TTM | 7.81% |
| EPS Q/Q | -95.96% |
| Sales Q/Q | 5.87% |
| Earnings | Oct 13 BMO |
| EPS/Sales Surpr. | 2.68% 0.06% |
Ownership
| Insider Own | 0.12% |
|---|---|
| Insider Trans | -8.53% |
| Inst Own | 77.48% |
| Inst Trans | 0.00% |
| ROA | 8.25% |
| ROE | 20.02% |
| ROIC | 13.72% |
| Gross Margin | 67.65% |
| Oper. Margin | 25.85% |
| Profit Margin | 16.20% |
| SMA20 | 4.43% |
| SMA50 | 5.20% |
| SMA200 | 12.52% |
| Trades | - |
Technical
| Shs Outstand | 2.41B |
|---|---|
| Shs Float | 2.40B |
| Short Float | 0.71% |
| Short Ratio | 2.44 |
| Short Interest | 17.07M |
| 52W High | 283.25 -1.00% |
| 52W Low | 189.05 48.33% |
| Volatility | 3.06% 2.58% |
| ATR (14) | 6.93 |
| RSI (14) | 61.58 |
| Beta | 0.20 |
| Rel Volume | 0.78 |
| Avg Volume | 6.98M |
| Volume | 5,432,723 |
Performance
| Perf Week | 1.48% |
|---|---|
| Perf Month | 12.79% |
| Perf Quarter | 6.99% |
| Perf Half Y | 21.70% |
| Perf YTD | 35.50% |
| Perf Year | 44.67% |
| Perf 3Y | 90.43% |
| Perf 5Y | 71.97% |
| Perf 10Y | 136.69% |
| Recom | 1.93 |
| Target Price | 283.67 |
| Prev Close | 280.78 |
| Price | 280.41 |
| Change % | -0.13% |
Analyst ratings
latest 10 of 20| Date | Action | Analyst | Rating change | Target | Implied |
|---|---|---|---|---|---|
| Oct 21, 2026 | Downgrade | EErste Group | Buy → Hold | ||
| Sep 02, 2026 | Resumed | UUBS | Buy | $320 | +14.1% |
| May 13, 2026 | Upgrade | LLeerink Partners | Market Perform → Outperform | $265 | -5.5% |
| Apr 08, 2026 | Resumed | TTD Cowen | Buy | $250 | -10.8% |
| Jan 28, 2026 | Upgrade | MMorgan Stanley | Equal-Weight → Overweight | $262 | -6.6% |
| Nov 13, 2025 | Initiated | BScotiabank | Sector Outperform | $230 | -18.0% |
| Oct 20, 2025 | Upgrade | DDaiwa Securities | Neutral → Outperform | $203 | -27.6% |
| Oct 03, 2025 | Upgrade | WWells Fargo | Equal Weight → Overweight | $212 | -24.4% |
| Sep 23, 2025 | Upgrade | GGuggenheim | Neutral → Buy | $206 | -26.5% |
| Jul 23, 2025 | Upgrade | EErste Group | Hold → Buy |
Peers
Mkt capInsider trading
latest 14 of 71| Insider | Relationship | Date | Transaction | Cost | Shares | Value | Total held | Form |
|---|---|---|---|---|---|---|---|---|
| Schmid Timothy | EVP, WW Chair, MedTech | Sep 02 '26 | Option Exercise | 144.99 | 33,597 | 4,871,389 | 47,974 | Sep 04 09:08 AM |
| Schmid Timothy | EVP, WW Chair, MedTech | Sep 02 '26 | Sale | 274.74 | 33,597 | 9,230,440 | 25,447 | Sep 04 09:08 AM |
| Schmid Timothy | Officer | Sep 02 '26 | Proposed Sale | 274.74 | 33,597 | 9,230,440 | Sep 02 11:26 AM | |
| Taubert Jennifer L | EVP, WWC. Innovative Medicine | Aug 17 '26 | Option Exercise | 115.67 | 15,000 | 1,735,050 | 209,451 | Aug 18 06:31 PM |
| Taubert Jennifer L | EVP, WWC. Innovative Medicine | Aug 17 '26 | Sale | 263.36 | 15,000 | 3,950,400 | 194,451 | Aug 18 06:31 PM |
| Taubert Jennifer L | Officer | Aug 17 '26 | Proposed Sale | 263.36 | 15,000 | 3,950,418 | Aug 17 12:51 PM | |
| Duato Joaquin | CEO and Chairman of the Board | Aug 13 '26 | Option Exercise | 115.67 | 123,291 | 14,261,070 | 399,258 | Aug 14 04:35 PM |
| Duato Joaquin | CEO and Chairman of the Board | Aug 13 '26 | Sale | 261.17 | 123,291 | 32,199,927 | 275,967 | Aug 14 04:35 PM |
| Duato Joaquin | Officer | Aug 13 '26 | Proposed Sale | 261.17 | 123,291 | 32,199,927 | Aug 13 02:12 PM | |
| Duato Joaquin | CEO and Chairman of the Board | Aug 05 '26 | Sale | 258.15 | 48,480 | 12,515,010 | 275,967 | Aug 07 05:50 PM |
| Forminard Elizabeth | EVP, Chief Legal Officer | Aug 06 '26 | Option Exercise | 131.94 | 9,344 | 1,232,847 | 32,912 | Aug 07 05:44 PM |
| Forminard Elizabeth | EVP, Chief Legal Officer | Aug 06 '26 | Sale | 257.00 | 15,918 | 4,090,960 | 16,994 | Aug 07 05:44 PM |
| Forminard Elizabeth | Officer | Aug 06 '26 | Proposed Sale | 257.00 | 15,918 | 4,090,957 | Aug 06 02:02 PM | |
| Joaquin Duato | CEO, Chariman | Aug 05 '26 | Proposed Sale | 254.93 | 48,480 | 12,359,006 | Aug 05 06:07 PM |
Held by
AUM| Ticker | Company | AUM |
|---|---|---|
| VTI | Vanguard Morningstar Total Stock Market ETF | AUM: 687.42B |
| VOO | Vanguard S&P 500 ETF | AUM: 1054.75B |
| IVV | iShares Core S&P 500 ETF | AUM: 871.38B |
| SPY | SPDR S&P 500 ETF Trust | AUM: 793.23B |
| VTV | Vanguard Morningstar Value ETF | AUM: 196.23B |
| XLV | State Street Health Care Select Sector SPDR ETF | AUM: 50.35B |
| VIG | Vanguard Dividend Appreciation FTF | AUM: 117.07B |
| VYM | Vanguard High Dividend Yield Indx ETF | AUM: 83.15B |
| VHT | Vanguard Health Care ETF | AUM: 21.51B |
| SPYM | State Street SPDR Portfolio S&P 500 ETF | AUM: 183.48B |
News
latest 14 of 100- J&J funds Francis Medical to seek cancer indication for Vanquish device (Medical Device Network)
- Healthcare Just Hit a Record Lead Over Tech. 3 Things Could Shrink It (BeInCrypto)
- Johnson & Johnson Announces CAPLYTA (lumateperone) Shows Significant and Rapid Improvement in Bipolar Mania in Second Pivotal Phase 3 Study (PR Newswire)
- Q3 Earnings Season Winners: 3 Companies Raising Guidance (Zacks)
- Raised Outlooks and a Cancer Approval Arrive in the Middle of Medicare Open Enrollment (PR Newswire)
- After Smith+Nephew's $34 Billion Merger Collapse, This Wound Care Stock Is Worth a Look (NASDAQ: MDWD) (FinanceWire)
- J&J Backs Psychedelic-Inspired Biotech in $100 Million Round (Bloomberg)
- Johnson & Johnson's ICOTYDE Meets Primary Endpoint in Phase 3 Psoriatic Arthritis Trial (InvestorsHub)
- FDA Decision Watch: Summits Lung Cancer Drug, Cytokinetics Heart Therapy And Tevas Igalmi In Spotlight This Week (Stocktwits)
- Johnson & Johnson announces new Phase 2 nipocalimab study data in Sjogren's disease that reveal insights on importance of symptom improvements most valued by patients (PR Newswire)
- Johnson & Johnson announces ICOTYDE (icotrokinra) delivers significant improvement in psoriatic arthritis disease activity among biologic-naive patients with once-daily targeted oral peptide (PR Newswire)
- Johnson & Johnson wins FDA approval for Rybrevant cancer treatment (Investing.com)
- Johnson & Johnson announces U.S. FDA Approval of RYBREVANT FASPRO (amivantamab and hyaluronidase-lpuj) as First and Only Dual-Targeted Therapy for Advanced Head and Neck Cancer (PR Newswire)
- Genmab nine-month revenue rises 22% as late-stage pipeline delivers (Investing.com)
Quarterly earnings
actual against estimate| Period | Reported | EPS act | EPS est | EPS rep | Sales act | Sales est | Analysts |
|---|---|---|---|---|---|---|---|
| 2026Q3 | 2026-10-13 | 2.590 | 2.522 | 0.090 | 25,399 | 25,383 | 15 |
| 2026Q2 | 2026-07-15 | 2.900 | 2.855 | 2.268 | 25,310 | 25,062 | 17 |
| 2026Q1 | 2026-04-14 | 2.700 | 2.677 | 2.141 | 24,062 | 23,615 | 18 |
| 2025Q4 | 2026-01-21 | 2.460 | 2.463 | 2.098 | 24,564 | 24,148 | 19 |
| 2025Q3 | 2025-10-14 | 2.800 | 2.757 | 2.121 | 23,993 | 23,755 | 18 |
| 2025Q2 | 2025-07-16 | 2.770 | 2.682 | 2.289 | 23,743 | 22,854 | 17 |
| 2025Q1 | 2025-04-15 | 2.770 | 2.581 | 4.538 | 21,893 | 21,559 | 17 |
| 2024Q4 | 2025-01-22 | 2.040 | 1.992 | 1.414 | 22,520 | 22,431 | 16 |
| 2024Q3 | 2024-10-15 | 2.420 | 2.207 | 1.110 | 22,471 | 22,172 | 16 |
| 2024Q2 | 2024-07-17 | 2.820 | 2.711 | 1.935 | 22,447 | 22,330 | 17 |
| 2024Q1 | 2024-04-16 | 2.710 | 2.656 | 1.339 | 21,383 | 21,401 | 16 |
| 2023Q4 | 2024-01-23 | 2.290 | 2.281 | 1.666 | 21,395 | 21,022 | 15 |
| 2023Q3 | 2023-10-17 | 2.660 | 2.516 | 1.978 | 21,351 | 21,036 | 14 |
| 2023Q2 | 2023-07-20 | 2.800 | 2.617 | 1.959 | 25,530 | 24,634 | 17 |
| 2023Q1 | 2023-04-18 | 2.680 | 2.503 | -0.026 | 24,746 | 23,599 | 17 |
| 2022Q4 | 2023-01-24 | 2.350 | 2.237 | 1.328 | 23,706 | 23,880 | 16 |
Annual earnings
| Period | EPS act | EPS est | EPS rep | Sales act | Sales est |
|---|---|---|---|---|---|
| 2019FY | 8.680 | 8.669 | 5.632 | 82,059 | 82,128 |
| 2020FY | 8.030 | 7.996 | 5.509 | 82,584 | 81,795 |
| 2021FY | 9.800 | 9.832 | 7.808 | 93,775 | 94,449 |
| 2022FY | 10.150 | 10.046 | 6.735 | 94,943 | 95,019 |
| 2023FY | 9.920 | 9.918 | 5.534 | 85,159 | 84,747 |
| 2024FY | 9.980 | 9.950 | 5.790 | 88,821 | 88,777 |
| 2025FY | 10.790 | 10.803 | 11.030 | 94,193 | 93,759 |
| 2026FY | - | 11.114 | - | - | 101,223 |
| 2027FY | - | 11.593 | - | - | 107,767 |
| 2028FY | - | 13.931 | - | - | 116,594 |
| 2029FY | - | 15.561 | - | - | 125,346 |
| 2030FY | - | 17.437 | - | - | 135,218 |
Estimate revisions
last 14 periods| Period | Type | Date | Estimates | Up | Down | Mean | Low | High |
|---|---|---|---|---|---|---|---|---|
| 2026Q4 | S | 2026-11-06 | 15 | 0 | 3 | 26,420 | 26,229 | 26,683 |
| 2026Q4 | S | 2026-10-26 | 15 | 0 | 3 | 26,420 | 26,229 | 26,683 |
| 2026Q4 | S | 2026-10-23 | 15 | 0 | 3 | 26,420 | 26,229 | 26,683 |
| 2026Q4 | S | 2026-10-16 | 15 | 0 | 3 | 26,420 | 26,229 | 26,683 |
| 2026Q4 | S | 2026-10-14 | 15 | 0 | 3 | 26,443 | 26,229 | 26,683 |
| 2026Q4 | S | 2026-10-13 | 15 | 0 | 3 | 26,450 | 26,229 | 26,683 |
| 2026Q4 | S | 2026-10-09 | 15 | 0 | 3 | 26,454 | 26,147 | 26,755 |
| 2026Q4 | S | 2026-10-08 | 15 | 0 | 3 | 26,455 | 26,147 | 26,755 |
| 2026Q4 | S | 2026-10-05 | 15 | 1 | 2 | 26,490 | 26,147 | 26,922 |
| 2026Q4 | S | 2026-10-01 | 15 | 1 | 1 | 26,513 | 26,309 | 26,922 |
| 2026Q4 | S | 2026-09-29 | 15 | 1 | 1 | 26,515 | 26,309 | 26,922 |
| 2026Q4 | S | 2026-09-28 | 15 | 1 | 1 | 26,509 | 26,309 | 26,922 |
| 2026Q4 | S | 2026-09-24 | 15 | 3 | 2 | 26,503 | 26,309 | 26,922 |
| 2026Q4 | S | 2026-09-18 | 15 | 3 | 2 | 26,503 | 26,309 | 26,922 |
Estimate history
| EPS, annual | 0.47 | 5.61 | 5.632 | 5.509 | 7.808 | 6.735 | 5.534 | 5.79 | 11.033 | 6.5922 |
|---|---|---|---|---|---|---|---|---|---|---|
| Period | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
| EPS, quarterly | 1.11 | 1.414 | 4.538 | 2.289 | 2.121 | 2.098 | 2.141 | 2.268 | 0.086 | |
| Period | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
| Sales, annual | 76481 | 81534 | 82113 | 82572 | 93758 | 80062 | 85152 | 88819 | 94178 | 99347 |
| Period | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
| Sales, quarterly | 22470 | 22519 | 21894 | 23741 | 23992 | 24562 | 24068 | 25317 | 25400 | |
| Period | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
| Shares, annual | 2682.525 | 2662.324 | 2632.507 | 2632.512 | 2628.965 | 2613.597 | 2407.078 | 2406.922 | 2407.939 | 2407.118 |
| Period | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | MRQ |
| Shares, quarterly | 2407.298 | 2406.922 | 2405.625 | 2406.779 | 2406.195 | 2407.939 | 2406.585 | 2408.228 | 2407.118 | |
| Period | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 |
Income statement, annual
| Metric | TTM | 2025FY | 2024FY | 2023FY | 2022FY | 2021FY | 2020FY | 2019FY | 2018FY |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 99,347.00 | 94,178.00 | 88,819.00 | 85,152.00 | 80,062.00 | 93,758.00 | 82,572.00 | 82,113.00 | 81,534.00 |
| Cost of Goods Sold Incl. D&A | 32,142.00 | 29,552.00 | 27,862.00 | 26,430.00 | 24,325.00 | 29,874.00 | 27,998.00 | 27,135.00 | 27,186.00 |
| Gross Profit | 67,205.00 | 64,626.00 | 60,957.00 | 58,722.00 | 55,737.00 | 63,884.00 | 54,574.00 | 54,978.00 | 54,348.00 |
| Selling, General and Administrative Excl. Other | 41,528.00 | 38,502.00 | 40,134.00 | 36,560.00 | 34,530.00 | 39,403.00 | 34,106.00 | 33,428.00 | 33,095.00 |
| Research and Development | 16,024.00 | 14,826.00 | 17,265.00 | 15,048.00 | 14,284.00 | 14,744.00 | 12,022.00 | 11,250.00 | 10,555.00 |
| Other Operating Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | 25,677.00 | 26,124.00 | 20,823.00 | 22,162.00 | 21,207.00 | 24,481.00 | 20,468.00 | 21,550.00 | 21,253.00 |
| Interest Expense | 1,620.00 | 1,490.00 | 1,150.00 | 1,177.00 | 841.00 | 759.00 | 724.00 | 769.00 | 1,194.00 |
| Unusual Expense | 9,369.60 | -5,424.00 | 6,241.80 | 9,309.30 | 3,662.20 | 3,350.00 | 3,876.00 | 6,008.00 | 4,138.00 |
| Net Income Before Taxes | 17,737.00 | 32,581.00 | 16,687.00 | 15,062.00 | 19,359.00 | 22,776.00 | 16,497.00 | 17,328.00 | 17,999.00 |
| Income Taxes | 1,642.00 | 5,777.00 | 2,621.00 | 1,736.00 | 2,989.00 | 1,898.00 | 1,783.00 | 2,209.00 | 2,702.00 |
| Consolidated Net Income | 16,095.00 | 26,804.00 | 14,066.00 | 13,326.00 | 16,370.00 | 20,878.00 | 14,714.00 | 15,119.00 | 15,297.00 |
| Net Income From Continuing Operations | 16,095.00 | 26,804.00 | 14,066.00 | 13,326.00 | 16,370.00 | 20,878.00 | 14,714.00 | 15,119.00 | 15,297.00 |
| Net Income | 16,095.00 | 26,804.00 | 14,066.00 | 14,169.00 | 17,941.00 | 20,878.00 | 14,714.00 | 15,119.00 | 15,297.00 |
| EPS (Recurring) | 9.25 | 9.47 | 7.59 | 8.08 | 7.70 | 8.68 | 6.53 | 7.20 | 6.67 |
| EPS (Basic, Before Extraordinaries) | 6.68 | 11.13 | 5.84 | 5.59 | 6.83 | 7.93 | 5.59 | 5.72 | 5.70 |
| EPS (Diluted) | 6.59 | 11.03 | 5.79 | 5.53 | 6.73 | 7.81 | 5.51 | 5.63 | 5.61 |
| EBITDA | 33,768.00 | 33,627.00 | 28,162.00 | 29,648.00 | 28,177.00 | 31,871.00 | 27,699.00 | 28,559.00 | 28,182.00 |
| Non-Operating Income (Expense) | 3,049.60 | 2,523.00 | 3,255.80 | 3,386.30 | 2,655.20 | 2,404.00 | 629.00 | 2,555.00 | 2,078.00 |
| Other After Tax Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock Option Compensation Expense | 4,177.52 | 1,117.00 | 925.00 | 866.00 | 851.00 | 917.00 | 795.00 | 750.00 | 786.00 |
| Price To Earnings Ratio | 42.59 | 42.59 | 23.91 | 29.92 | 24.59 | 21.90 | 28.55 | 25.90 | 23.00 |
| Price To Sales Ratio | 6.68 | 5.36 | 3.97 | 4.71 | 5.88 | 4.88 | 5.09 | 4.76 | 4.26 |
| Gross Margin | 67.65 | 68.62 | 68.63 | 68.96 | 69.62 | 68.14 | 66.09 | 66.95 | 66.66 |
| Operating Margin | 25.85 | 27.74 | 23.44 | 26.03 | 26.49 | 26.11 | 24.79 | 26.24 | 26.07 |
| Net Margin | 16.20 | 28.46 | 15.84 | 16.64 | 22.41 | 22.27 | 17.82 | 18.41 | 18.76 |
| Shares Outstanding | 2,407.12 | 2,407.94 | 2,406.92 | 2,407.08 | 2,613.60 | 2,628.97 | 2,632.51 | 2,632.51 | 2,662.32 |
| Market Capitalization | 675,924.50 | 675,924.50 | 348,190.00 | 377,317.07 | 461,847.89 | 450,358.88 | 414,309.15 | 383,910.88 | 346,109.52 |
Income statement, quarterly
| Metric | 2026Q3 | 2026Q2 | 2026Q1 | 2025Q4 | 2025Q3 | 2025Q2 | 2025Q1 | 2024Q4 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 25,400.00 | 25,317.00 | 24,068.00 | 24,562.00 | 23,992.00 | 23,741.00 | 21,894.00 | 22,519.00 |
| Cost of Goods Sold Incl. D&A | 8,100.00 | 7,916.00 | 7,964.00 | 8,162.00 | 7,265.00 | 7,481.00 | 7,259.00 | 7,231.00 |
| Gross Profit | 17,300.00 | 17,401.00 | 16,104.00 | 16,400.00 | 16,727.00 | 16,260.00 | 14,635.00 | 15,288.00 |
| Selling, General and Administrative Excl. Other | 10,943.00 | 10,035.00 | 9,529.00 | 11,021.00 | 9,615.00 | 9,421.00 | 8,338.00 | 11,772.00 |
| Research and Development | 4,658.00 | 3,603.00 | 3,495.00 | 4,268.00 | 3,693.00 | 3,532.00 | 3,226.00 | 5,319.00 |
| Other Operating Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | 6,357.00 | 7,366.00 | 6,575.00 | 5,379.00 | 7,112.00 | 6,839.00 | 6,297.00 | 3,516.00 |
| Interest Expense | 349.00 | 363.00 | 418.00 | 490.00 | 377.00 | 432.00 | 287.00 | 268.00 |
| Unusual Expense | 6,444.00 | 1,127.00 | 766.00 | 1,032.60 | 39.70 | 450.00 | -6,820.00 | -34.00 |
| Net Income Before Taxes | 34.00 | 6,747.00 | 5,990.00 | 4,966.00 | 7,493.00 | 6,491.00 | 13,631.00 | 3,887.00 |
| Income Taxes | -176.00 | 1,213.00 | 755.00 | -150.00 | 2,341.00 | 954.00 | 2,632.00 | 456.00 |
| Consolidated Net Income | 210.00 | 5,534.00 | 5,235.00 | 5,116.00 | 5,152.00 | 5,537.00 | 10,999.00 | 3,431.00 |
| Net Income From Continuing Operations | 210.00 | 5,534.00 | 5,235.00 | 5,116.00 | 5,152.00 | 5,537.00 | 10,999.00 | 3,431.00 |
| Net Income | 210.00 | 5,534.00 | 5,235.00 | 5,116.00 | 5,152.00 | 5,537.00 | 10,999.00 | 3,431.00 |
| EPS (Recurring) | 1.93 | 2.59 | 2.36 | 2.39 | 2.13 | 2.42 | 2.57 | 1.40 |
| EPS (Basic, Before Extraordinaries) | 0.09 | 2.30 | 2.17 | 2.12 | 2.14 | 2.30 | 4.57 | 1.43 |
| EPS (Diluted) | 0.09 | 2.27 | 2.14 | 2.10 | 2.12 | 2.29 | 4.54 | 1.41 |
| EBITDA | 8,474.00 | 9,325.00 | 8,579.00 | 7,390.00 | 8,889.00 | 8,782.00 | 8,069.00 | 5,412.00 |
| Non-Operating Income (Expense) | 470.00 | 871.00 | 599.00 | 1,109.60 | 797.70 | 534.00 | 801.00 | 605.00 |
| Other After Tax Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock Option Compensation Expense | 869.79 | 645.43 | 1,163.67 | 1,498.63 | 1,279.80 | 410.01 | 582.23 | 285.98 |
| Price To Earnings Ratio | 42.59 | 29.36 | 22.13 | 19.97 | 19.83 | 16.98 | 28.61 | 23.91 |
| Price To Sales Ratio | 6.68 | 6.34 | 6.10 | 5.38 | 4.74 | 4.07 | 4.44 | 3.96 |
| Gross Margin | 68.11 | 68.73 | 66.91 | 66.77 | 69.72 | 68.49 | 66.84 | 67.89 |
| Operating Margin | 25.03 | 29.10 | 27.32 | 21.90 | 29.64 | 28.81 | 28.76 | 15.61 |
| Net Margin | 0.83 | 21.86 | 21.75 | 20.83 | 21.47 | 23.32 | 50.24 | 15.24 |
| Shares Outstanding | 2,407.12 | 2,408.23 | 2,406.59 | 2,407.94 | 2,406.20 | 2,406.78 | 2,405.62 | 2,406.92 |
| Market Capitalization | 675,924.50 | 611,361.66 | 589,075.96 | 498,604.64 | 446,554.40 | 367,527.19 | 399,649.52 | 348,190.00 |
Balance sheet, annual
| Metric | 2025FY | 2024FY | 2023FY | 2022FY | 2021FY | 2020FY | 2019FY | 2018FY | 2017FY |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Short Term Investments | 20,102.00 | 24,522.00 | 22,927.00 | 22,281.00 | 31,608.00 | 25,185.00 | 19,287.00 | 19,687.00 | 18,296.00 |
| Short Term Receivables | 17,178.00 | 14,842.00 | 14,873.00 | 14,039.00 | 15,283.00 | 13,576.00 | 14,481.00 | 14,098.00 | 13,490.00 |
| Inventories | 14,191.00 | 12,444.00 | 11,181.00 | 10,268.00 | 10,387.00 | 9,344.00 | 9,020.00 | 8,599.00 | 8,765.00 |
| Other Current Assets | 4,153.00 | 4,085.00 | 4,514.00 | 8,706.00 | 3,701.00 | 3,132.00 | 2,486.00 | 3,649.00 | 2,537.00 |
| Total Current Assets | 55,624.00 | 55,893.00 | 53,495.00 | 55,294.00 | 60,979.00 | 51,237.00 | 45,274.00 | 46,033.00 | 43,088.00 |
| Net Property, Plant & Equipment | 24,469.00 | 21,618.00 | 20,898.00 | 18,982.00 | 19,862.00 | 19,766.00 | 18,615.00 | 17,035.00 | 17,005.00 |
| Total Investments and Advances | 665.00 | 451.00 | 4,473.00 | 576.00 | 1,884.00 | 1,481.00 | 1,148.00 | 511.00 | 751.00 |
| Intangible Assets | 99,175.00 | 81,818.00 | 70,733.00 | 74,536.00 | 81,638.00 | 89,795.00 | 81,282.00 | 78,064.00 | 85,134.00 |
| Deferred Tax Assets | 6,874.00 | 10,461.00 | 9,279.00 | 8,947.00 | 10,223.00 | 8,534.00 | 7,819.00 | 7,640.00 | 7,105.00 |
| Other Assets | 12,403.00 | 9,863.00 | 8,680.00 | 29,043.00 | 7,432.00 | 4,081.00 | 3,590.00 | 3,671.00 | 4,220.00 |
| Total Assets | 199,210.00 | 180,104.00 | 167,558.00 | 187,378.00 | 182,018.00 | 174,894.00 | 157,728.00 | 152,954.00 | 157,303.00 |
| Short Term Debt Incl. Current Port. of LT Debt | 8,495.00 | 5,983.00 | 3,451.00 | 12,756.00 | 3,766.00 | 2,631.00 | 1,471.00 | 2,796.00 | 3,906.00 |
| Accounts Payable | 11,991.00 | 10,311.00 | 9,632.00 | 9,889.00 | 11,055.00 | 9,505.00 | 8,544.00 | 7,537.00 | 7,310.00 |
| Income Tax Payable | 1,388.00 | 3,772.00 | 2,993.00 | 2,220.00 | 1,112.00 | 1,392.00 | 2,266.00 | 818.00 | 1,854.00 |
| Other Current Liabilities | 32,252.00 | 30,255.00 | 30,206.00 | 30,937.00 | 29,293.00 | 28,965.00 | 23,683.00 | 20,079.00 | 17,467.00 |
| Total Current Liabilities | 54,126.00 | 50,321.00 | 46,282.00 | 55,802.00 | 45,226.00 | 42,493.00 | 35,964.00 | 31,230.00 | 30,537.00 |
| Long Term Debt | 40,838.00 | 31,851.00 | 26,981.00 | 27,986.00 | 30,985.00 | 33,735.00 | 27,210.00 | 27,684.00 | 30,675.00 |
| Provision for Risks Charges | 6,957.00 | 7,255.00 | 7,149.00 | 6,542.00 | 8,898.00 | 10,771.00 | 10,663.00 | 9,951.00 | 10,074.00 |
| Deferred Tax Liabilities | 6,791.00 | 2,448.00 | 3,193.00 | 3,991.00 | 7,487.00 | 7,214.00 | 5,958.00 | 7,506.00 | 8,368.00 |
| Other Liabilities | 8,954.00 | 16,739.00 | 15,179.00 | 16,253.00 | 15,399.00 | 17,403.00 | 18,462.00 | 16,831.00 | 17,489.00 |
| Total Liabilities | 117,666.00 | 108,614.00 | 98,784.00 | 110,574.00 | 107,995.00 | 111,616.00 | 98,257.00 | 93,202.00 | 97,143.00 |
| Non-Equity Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock - Carrying Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Equity | 81,544.00 | 71,490.00 | 68,774.00 | 76,804.00 | 74,023.00 | 63,278.00 | 59,471.00 | 59,752.00 | 60,160.00 |
| Total Shareholders Equity | 81,544.00 | 71,490.00 | 68,774.00 | 76,804.00 | 74,023.00 | 63,278.00 | 59,471.00 | 59,752.00 | 60,160.00 |
| Accumulated Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Equity | 81,544.00 | 71,490.00 | 68,774.00 | 76,804.00 | 74,023.00 | 63,278.00 | 59,471.00 | 59,752.00 | 60,160.00 |
| Total Liabilities & Stockholders Equity | 199,210.00 | 180,104.00 | 167,558.00 | 187,378.00 | 182,018.00 | 174,894.00 | 157,728.00 | 152,954.00 | 157,303.00 |
| Book Value Per Share | 33.86 | 29.70 | 28.57 | 29.39 | 28.16 | 24.04 | 22.59 | 22.44 | 22.43 |
| Tangible Book Value Per Share | -7.32 | -4.29 | -0.81 | 0.87 | -2.90 | -10.07 | -8.29 | -6.88 | -9.31 |
| Full-Time Employees | 140,800 | 139,800 | 131,900 | 152,700 | 141,700 | 134,500 | 132,200 | 135,100 | 134,000 |
| Price to Book Ratio | 8.29 | 4.96 | 5.30 | 6.20 | 6.08 | 6.55 | 6.46 | 5.75 | 5.07 |
| Return on Assets | 14.13 | 8.09 | 7.51 | 8.86 | 11.70 | 8.85 | 9.73 | 9.86 | 0.87 |
| Return on Equity | 35.03 | 20.06 | 18.31 | 21.71 | 30.41 | 23.97 | 25.36 | 25.51 | 1.99 |
| Return on Invested Capital | 21.90 | 13.61 | 14.80 | 17.12 | 19.88 | 15.17 | 17.44 | 17.50 | 1.43 |
| Quick Ratio | 0.77 | 0.86 | 0.91 | 0.81 | 1.12 | 0.99 | 1.01 | 1.20 | 1.12 |
| Current Ratio | 1.03 | 1.11 | 1.16 | 0.99 | 1.35 | 1.21 | 1.26 | 1.47 | 1.41 |
Cash flow, annual
| Metric | TTM | 2025FY | 2024FY | 2023FY | 2022FY | 2021FY | 2020FY | 2019FY | 2018FY |
|---|---|---|---|---|---|---|---|---|---|
| Net Income | 16,095.00 | 26,804.00 | 14,066.00 | 35,153.00 | 17,941.00 | 20,878.00 | 14,714.00 | 15,119.00 | 15,297.00 |
| Depreciation | 8,091.00 | 7,503.00 | 7,339.00 | 7,486.00 | 6,970.00 | 7,390.00 | 7,231.00 | 7,009.00 | 6,929.00 |
| Other Funds (Non Cash) | 3,121.00 | 1,403.00 | 3,207.00 | -18,161.00 | 1,957.00 | 1,459.00 | 42.00 | -101.00 | 988.00 |
| Funds from Operations | 21,520.00 | 37,248.00 | 22,429.00 | 20,284.00 | 25,205.00 | 27,648.00 | 20,846.00 | 19,551.00 | 22,198.00 |
| Extraordinary Item | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes in Working Capital | 4,639.00 | -12,718.00 | 1,837.00 | 2,507.00 | -4,011.00 | -4,238.00 | 2,690.00 | 3,865.00 | 3.00 |
| Cash from Operating Activities | 26,159.00 | 24,530.00 | 24,266.00 | 22,791.00 | 21,194.00 | 23,410.00 | 23,536.00 | 23,416.00 | 22,201.00 |
| Capital Expenditures | -6,179.00 | -4,832.00 | -4,424.00 | -4,543.00 | -4,009.00 | -3,652.00 | -3,347.00 | -3,498.00 | -3,670.00 |
| Net Assets From Acquisitions | -3,434.00 | -17,541.00 | -15,146.00 | 0.00 | -17,652.00 | -60.00 | -7,323.00 | -5,810.00 | -899.00 |
| Sale of Fixed Assets and Businesses | 400.00 | 720.00 | 675.00 | 358.00 | 543.00 | 711.00 | 305.00 | 3,265.00 | 3,203.00 |
| Purchase or Sale of Investments | -566.00 | 741.00 | 736.00 | 8,484.00 | 9,225.00 | -5,388.00 | -8,952.00 | -533.00 | -1,337.00 |
| Purchase of Investments | -1,461.00 | -920.00 | -1,726.00 | -10,906.00 | -32,384.00 | -30,394.00 | -21,089.00 | -3,920.00 | -5,626.00 |
| Sale Or Maturity of Investments | 895.00 | 1,661.00 | 2,462.00 | 19,390.00 | 41,609.00 | 25,006.00 | 12,137.00 | 3,387.00 | 4,289.00 |
| Other Uses | -438.00 | -2,676.00 | -1,957.00 | -3,433.00 | -478.00 | -508.00 | -1,508.00 | 0.00 | -464.00 |
| Other Sources | 873.00 | 0.00 | 1,517.00 | 12.00 | 0.00 | 214.00 | 0.00 | 382.00 | 0.00 |
| Cash from Investing Activities | -9,344.00 | -23,588.00 | -18,599.00 | 878.00 | -12,371.00 | -8,683.00 | -20,825.00 | -6,194.00 | -3,167.00 |
| Cash Dividends Paid | -12,716.00 | -12,381.00 | -11,823.00 | -11,770.00 | -11,682.00 | -11,032.00 | -10,481.00 | -9,917.00 | -9,494.00 |
| Change in Capital Stock | -4,021.00 | -2,535.00 | -1,594.00 | 8,328.00 | -4,706.00 | -2,420.00 | -2,107.00 | -5,792.00 | -4,919.00 |
| Repurchase of Common Pref Stock | -7,882.00 | -5,953.00 | -2,432.00 | -5,054.00 | -6,035.00 | -3,456.00 | -3,221.00 | -6,746.00 | -5,868.00 |
| Sale of Common Pref Stock | 3,861.00 | 3,418.00 | 838.00 | 13,382.00 | 1,329.00 | 1,036.00 | 1,114.00 | 954.00 | 949.00 |
| Proceedsfrom Stock Options | 0.00 | 0.00 | 0.00 | 12,288.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Issuance or Reduction of Debt, Net | -787.00 | 9,637.00 | 10,051.00 | -10,781.00 | 7,452.00 | -990.00 | 7,095.00 | -2,881.00 | -3,949.00 |
| Change in Long Term Debt | -2,006.00 | 7,381.00 | 5,207.00 | -1,551.00 | -2,132.00 | -1,797.00 | 6,367.00 | -2,820.00 | -1,550.00 |
| Issuance of Long Term Debt | 0.00 | 9,138.00 | 6,660.00 | 0.00 | 2.00 | 5.00 | 7,431.00 | 3.00 | 5.00 |
| Reduction of Long Term Debt | -2,006.00 | -1,757.00 | -1,453.00 | -1,551.00 | -2,134.00 | -1,802.00 | -1,064.00 | -2,823.00 | -1,555.00 |
| Net Financing Active Other Cash Flow | -625.00 | -260.00 | 234.00 | -1,602.00 | 65.00 | 395.00 | -627.00 | 575.00 | -148.00 |
| Other Financing Activities Uses | -625.00 | -260.00 | -38.00 | -1,602.00 | -28.00 | 0.00 | -627.00 | 0.00 | -148.00 |
| Cash from Financing Activities | -18,149.00 | -5,539.00 | -3,132.00 | -15,825.00 | -8,871.00 | -14,047.00 | -6,120.00 | -18,015.00 | -18,510.00 |
| Exchange Rate Effect | 13.00 | 201.00 | -289.00 | -112.00 | -312.00 | -178.00 | 89.00 | -9.00 | -241.00 |
| Net Change in Cash | -1,321.00 | -4,396.00 | 2,246.00 | 7,732.00 | -360.00 | 502.00 | -3,320.00 | -802.00 | 283.00 |
| Free Cash Flow | 20,590.00 | 19,698.00 | 19,842.00 | 18,248.00 | 17,185.00 | 19,758.00 | 20,189.00 | 19,918.00 | 18,531.00 |
| Preferred Dividends (Cash Flow) | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price to Free Cash Flow | 84.34 | 68.94 | 43.94 | 61.95 | 85.51 | 52.42 | 43.30 | 39.12 | 38.43 |
| Deferred Taxes & Investment Tax Credit | - | 1,538.00 | -2,183.00 | -4,194.00 | -1,663.00 | -2,079.00 | -1,141.00 | -2,476.00 | -1,016.00 |
Balance sheet, quarterly
| Metric | 2026Q3 | 2026Q2 | 2026Q1 | 2025Q4 | 2025Q3 | 2025Q2 |
|---|---|---|---|---|---|---|
| Cash & Short Term Investments | 17,228.00 | 20,758.00 | 22,051.00 | 20,102.00 | 18,562.00 | 18,880.00 |
| Short Term Receivables | 18,987.00 | 19,046.00 | 17,721.00 | 17,178.00 | 17,611.00 | 17,846.00 |
| Inventories | 15,377.00 | 15,144.00 | 14,583.00 | 14,191.00 | 14,146.00 | 13,412.00 |
| Other Current Assets | 4,759.00 | 4,826.00 | 4,818.00 | 4,153.00 | 4,292.00 | 4,360.00 |
| Total Current Assets | 56,351.00 | 59,774.00 | 59,173.00 | 55,624.00 | 54,611.00 | 54,498.00 |
| Net Property, Plant & Equipment | 24,104.00 | 23,582.00 | 23,270.00 | 24,469.00 | 22,338.00 | 21,949.00 |
| Total Investments and Advances | 824.00 | 803.00 | 703.00 | 665.00 | 573.00 | 453.00 |
| Intangible Assets | 95,126.00 | 96,708.00 | 97,619.00 | 99,175.00 | 96,785.00 | 97,952.00 |
| Deferred Tax Assets | 6,748.00 | 6,728.00 | 6,727.00 | 6,874.00 | 6,666.00 | 6,801.00 |
| Other Assets | 14,272.00 | 13,466.00 | 13,402.00 | 12,403.00 | 11,843.00 | 11,736.00 |
| Total Assets | 197,425.00 | 201,061.00 | 200,894.00 | 199,210.00 | 192,816.00 | 193,389.00 |
| Short Term Debt Incl. Current Port. of LT Debt | 8,852.00 | 11,692.00 | 17,460.00 | 8,495.00 | 6,387.00 | 11,526.00 |
| Accounts Payable | 9,317.00 | 9,223.00 | 10,460.00 | 11,991.00 | 9,625.00 | 9,464.00 |
| Income Tax Payable | 1,976.00 | 1,051.00 | 1,087.00 | 1,388.00 | 1,928.00 | 1,665.00 |
| Other Current Liabilities | 35,312.00 | 32,929.00 | 28,709.00 | 32,252.00 | 32,929.00 | 31,525.00 |
| Total Current Liabilities | 55,457.00 | 54,895.00 | 57,716.00 | 54,126.00 | 50,869.00 | 54,180.00 |
| Long Term Debt | 35,799.00 | 37,344.00 | 37,527.00 | 40,838.00 | 39,408.00 | 39,235.00 |
| Provision for Risks Charges | 6,559.00 | 6,657.00 | 6,760.00 | 6,957.00 | 6,930.00 | 7,021.00 |
| Deferred Tax Liabilities | 4,835.00 | 6,608.00 | 7,011.00 | 6,791.00 | 5,988.00 | 3,799.00 |
| Other Liabilities | 13,246.00 | 10,586.00 | 10,694.00 | 8,954.00 | 10,344.00 | 10,681.00 |
| Total Liabilities | 115,896.00 | 116,090.00 | 119,708.00 | 117,666.00 | 113,539.00 | 114,916.00 |
| Non-Equity Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock - Carrying Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Equity | 81,529.00 | 84,971.00 | 81,186.00 | 81,544.00 | 79,277.00 | 78,473.00 |
| Total Shareholders Equity | 81,529.00 | 84,971.00 | 81,186.00 | 81,544.00 | 79,277.00 | 78,473.00 |
| Accumulated Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Equity | 81,529.00 | 84,971.00 | 81,186.00 | 81,544.00 | 79,277.00 | 78,473.00 |
| Total Liabilities & Stockholders Equity | 197,425.00 | 201,061.00 | 200,894.00 | 199,210.00 | 192,816.00 | 193,389.00 |
| Book Value Per Share | 33.87 | 35.28 | 33.73 | 33.86 | 32.95 | 32.60 |
| Tangible Book Value Per Share | -5.65 | -4.87 | -6.83 | -7.32 | -7.28 | -8.09 |
| Full-Time Employees | - | - | - | 140,800 | - | - |
| Price to Book Ratio | 8.29 | 7.53 | 7.22 | 6.28 | 5.69 | 4.70 |
| Return on Assets | 8.25 | 10.67 | 10.66 | 14.13 | 13.54 | 12.10 |
| Return on Equity | 20.02 | 25.74 | 26.42 | 35.03 | 33.62 | 30.21 |
| Return on Invested Capital | 0.18 | 4.52 | 4.41 | 4.18 | 4.34 | 4.70 |
| Quick Ratio | 0.74 | 0.81 | 0.77 | 0.77 | 0.80 | 0.76 |
| Current Ratio | 1.02 | 1.09 | 1.03 | 1.03 | 1.07 | 1.01 |
Cash flow, quarterly
| Metric | 2026Q3 | 2026Q2 | 2026Q1 | 2025Q4 | 2025Q3 | 2025Q2 |
|---|---|---|---|---|---|---|
| Net Income | 210.00 | 5,534.00 | 5,235.00 | 5,116.00 | 5,152.00 | 5,537.00 |
| Depreciation | 2,117.00 | 1,959.00 | 2,004.00 | 2,011.00 | 1,777.00 | 1,943.00 |
| Other Funds (Non Cash) | 1,933.00 | 583.00 | 342.00 | 263.00 | 391.00 | 494.00 |
| Funds from Operations | 2,470.00 | 7,597.00 | 7,740.00 | 3,713.00 | 9,538.00 | 8,799.00 |
| Extraordinary Item | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes in Working Capital | 5,250.00 | 1,019.00 | -5,226.00 | 3,596.00 | -369.00 | -4,921.00 |
| Cash from Operating Activities | 7,720.00 | 8,616.00 | 2,514.00 | 7,309.00 | 9,169.00 | 3,878.00 |
| Capital Expenditures | -2,357.00 | -1,321.00 | -1,049.00 | -1,452.00 | -1,173.00 | -1,398.00 |
| Net Assets From Acquisitions | -89.00 | -263.00 | 0.00 | -3,082.00 | -1.00 | -14,458.00 |
| Sale of Fixed Assets and Businesses | -4.00 | 63.00 | 29.00 | 312.00 | 76.00 | 53.00 |
| Purchase or Sale of Investments | -611.00 | 4.00 | 65.00 | -24.00 | 243.00 | 555.00 |
| Purchase of Investments | -919.00 | -155.00 | -144.00 | -243.00 | -246.00 | -180.00 |
| Sale Or Maturity of Investments | 308.00 | 159.00 | 209.00 | 219.00 | 489.00 | 735.00 |
| Other Uses | -6.00 | -108.00 | -85.00 | -239.00 | 313.00 | -2,720.00 |
| Other Sources | 358.00 | 515.00 | 0.00 | 0.00 | - | - |
| Cash from Investing Activities | -2,709.00 | -1,110.00 | -1,040.00 | -4,485.00 | -542.00 | -18,264.00 |
| Cash Dividends Paid | -3,227.00 | -3,227.00 | -3,131.00 | -3,131.00 | -3,132.00 | -3,129.00 |
| Preferred Dividends (Cash Flow) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Capital Stock | -966.00 | 138.00 | -2,856.00 | -337.00 | -628.00 | 107.00 |
| Repurchase of Common Pref Stock | -1,709.00 | -221.00 | -4,028.00 | -1,924.00 | -1,902.00 | 0.00 |
| Sale of Common Pref Stock | 743.00 | 359.00 | 1,172.00 | 1,587.00 | 1,274.00 | 107.00 |
| Proceedsfrom Stock Options | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Issuance or Reduction of Debt, Net | -4,358.00 | -5,748.00 | 7,214.00 | 2,105.00 | -5,143.00 | -2,376.00 |
| Change in Long Term Debt | -1.00 | -1.00 | -2,002.00 | -2.00 | -1,001.00 | -3.00 |
| Issuance of Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reduction of Long Term Debt | -1.00 | -1.00 | -2,002.00 | -2.00 | -1,001.00 | -3.00 |
| Net Financing Active Other Cash Flow | 18.00 | 60.00 | -697.00 | -6.00 | -24.00 | -267.00 |
| Other Financing Activities Uses | 18.00 | 60.00 | -697.00 | -6.00 | 17.00 | -268.00 |
| Cash from Financing Activities | -8,533.00 | -8,777.00 | 530.00 | -1,369.00 | -8,927.00 | -5,665.00 |
| Exchange Rate Effect | 10.00 | 5.00 | -25.00 | 23.00 | -46.00 | 154.00 |
| Net Change in Cash | -3,512.00 | -1,266.00 | 1,979.00 | 1,478.00 | -346.00 | -19,897.00 |
| Free Cash Flow | 6,358.00 | 7,295.00 | 1,465.00 | 5,472.00 | 8,012.00 | 2,835.00 |
| Price to Free Cash Flow | 84.34 | 64.57 | 111.76 | 69.21 | 59.28 | 57.06 |
Revenue breakdown
| Asia-Pacific and Africa | 2024: 13.59B 2025: 14.03B |
|---|---|
| Europe | 2024: 20.21B 2025: 21.54B |
| United States | 2024: 50.30B 2025: 53.75B |
| Western Hemisphere excluding US | 2024: 4.71B 2025: 4.88B |
| Innovative Medicine | 2024: 56.96B 2025: 60.40B |
| MedTech | 2024: 31.86B 2025: 33.79B |
Short interest
shares short against float, oldest to newest| Settlement | Of float | Shares short | Float | Avg volume |
|---|---|---|---|---|
| 2026-10-30 | 0.71% | 17.1M | 2404.4M | 6.89M |
| 2026-10-15 | 0.70% | 16.8M | 2404.4M | 7.15M |
| 2026-09-30 | 0.92% | 22.1M | 2407.0M | 6.97M |
| 2026-09-15 | 0.88% | 21.2M | 2407.0M | 7.60M |
| 2026-08-31 | 0.90% | 21.7M | 2406.6M | 7.85M |
| 2026-08-14 | 0.90% | 21.6M | 2406.6M | 8.15M |
| 2026-07-31 | 1.06% | 25.4M | 2406.7M | 8.25M |
| 2026-07-15 | 1.14% | 27.4M | 2404.0M | 8.18M |
| 2026-06-30 | 1.11% | 26.6M | 2404.0M | 8.11M |
| 2026-06-15 | 1.11% | 26.7M | 2401.9M | 7.70M |
| 2026-05-29 | 0.97% | 23.4M | 2404.0M | 7.70M |
| 2026-05-15 | 0.96% | 23.0M | 2404.0M | 7.99M |
| 2026-04-30 | 0.93% | 22.3M | 2403.8M | 8.26M |
| 2026-04-15 | 0.82% | 19.7M | 2405.3M | 8.62M |
| 2026-03-31 | 0.93% | 22.3M | 2405.4M | 8.90M |
| 2026-03-13 | 0.97% | 23.3M | 2406.7M | 8.82M |
| 2026-02-27 | 1.04% | 25.1M | 2406.7M | 8.95M |
| 2026-02-13 | 0.86% | 20.8M | 2406.7M | 9.18M |
| 2026-01-30 | 0.81% | 19.6M | 2406.4M | 8.88M |
| 2026-01-15 | 0.89% | 21.3M | 2406.4M | 8.50M |
Option chain
expiry 2026-11-13| Type | Strike | Bid | Ask | Last | IV | Open int | Volume | Delta | Theta | Vega |
|---|---|---|---|---|---|---|---|---|---|---|
| call | 140 | 139.05 | 142.4 | 140.12 | 6.285 | 2.00 | 0.00 | 0.999 | -0.035 | 0.000 |
| call | 145 | 134.05 | 137.1 | 135.12 | 5.726 | 3.00 | 0.00 | 0.999 | -0.035 | 0.000 |
| call | 150 | 129.05 | 132.4 | 131.5 | 5.743 | 3.00 | 0.00 | 0.999 | -0.036 | 0.000 |
| call | 155 | 124.05 | 127.4 | 125.07 | 5.485 | 3.00 | 0.00 | 0.999 | -0.036 | 0.000 |
| call | 160 | 119.5 | 121.8 | 120.07 | 4.792 | 1.00 | 0.00 | 0.999 | -0.037 | 0.000 |
| call | 165 | 114.05 | 117.05 | 115.82 | 4.718 | 1.00 | 0.00 | 0.999 | -0.037 | 0.001 |
| call | 170 | 109.55 | 112.4 | 111.8 | 4.780 | 2.00 | 0.00 | 0.999 | -0.037 | 0.001 |
| call | 175 | 104.05 | 106.9 | 106.8 | 4.189 | 2.00 | 0.00 | 0.999 | -0.038 | 0.001 |
| call | 180 | 99.05 | 102.4 | 0.00 | 4.255 | 0.00 | 0.00 | 0.999 | -0.038 | 0.001 |
| call | 185 | 94.50 | 97.40 | 0.00 | 4.037 | 0.00 | 0.00 | 0.999 | -0.038 | 0.001 |
| call | 190 | 89.80 | 92.20 | 0.00 | 3.713 | 0.00 | 0.00 | 0.999 | -0.039 | 0.001 |
| call | 195 | 84.10 | 87.40 | 0.00 | 3.617 | 0.00 | 0.00 | 0.999 | -0.039 | 0.001 |
| call | 200 | 79.80 | 82.20 | 75.46 | 3.310 | 10.00 | 0.00 | 0.999 | -0.039 | 0.001 |
| call | 205 | 73.85 | 77.45 | 0.00 | 3.269 | 0.00 | 0.00 | 0.999 | -0.040 | 0.001 |
| call | 210 | 69.05 | 72.40 | 0.00 | 2.997 | 0.00 | 0.00 | 0.999 | -0.040 | 0.001 |
| call | 215 | 64.05 | 67.45 | 0.00 | 2.822 | 0.00 | 0.00 | 0.999 | -0.040 | 0.001 |
| call | 220 | 59.05 | 61.90 | 53.00 | 2.435 | 1.00 | 0.00 | 0.998 | -0.040 | 0.001 |
| call | 225 | 54.60 | 57.45 | 0.00 | 2.443 | 0.00 | 0.00 | 0.998 | -0.040 | 0.001 |
| call | 230 | 49.05 | 52.25 | 47.73 | 2.194 | 6.00 | 4.00 | 0.998 | -0.041 | 0.001 |
| call | 232.5 | 47.10 | 50.00 | 48.88 | 2.206 | 1.00 | 0.00 | 0.997 | -0.064 | 0.002 |
| call | 235 | 44.80 | 46.85 | 47.03 | 1.888 | 2.00 | 0.00 | 0.996 | -0.064 | 0.002 |
| call | 237.5 | 41.40 | 44.95 | 44.53 | 2.020 | 1.00 | 0.00 | 0.996 | -0.064 | 0.002 |
| call | 240 | 39.60 | 42.45 | 33.25 | 1.926 | 2.00 | 0.00 | 0.996 | -0.064 | 0.002 |
| call | 242.5 | 37.10 | 39.95 | 31.00 | 1.871 | 1.00 | 0.00 | 0.994 | -0.084 | 0.003 |
| call | 245 | 34.10 | 37.45 | 36.00 | 1.703 | 17.00 | 0.00 | 0.994 | -0.083 | 0.003 |
| call | 247.5 | 31.60 | 35.00 | 0.00 | 1.647 | 0.00 | 0.00 | 0.993 | -0.083 | 0.004 |
| call | 250 | 29.35 | 32.05 | 31.09 | 1.421 | 395 | 4.00 | 0.993 | -0.082 | 0.004 |
| call | 252.5 | 27.10 | 29.95 | 0.00 | 1.461 | 0.00 | 0.00 | 0.992 | -0.083 | 0.004 |
| call | 255 | 24.60 | 27.15 | 22.83 | 1.267 | 85.00 | 1.00 | 0.988 | -0.111 | 0.006 |
| call | 257.5 | 22.10 | 24.70 | 22.27 | 1.187 | 33.00 | 0.00 | 0.978 | -0.187 | 0.011 |
| call | 260 | 19.55 | 22.20 | 17.31 | 1.095 | 199 | 1.00 | 0.967 | -0.246 | 0.015 |
| call | 262.5 | 17.15 | 19.55 | 15.05 | 0.972 | 25.00 | 0.00 | 0.956 | -0.294 | 0.019 |
| call | 265 | 14.90 | 16.95 | 15.47 | 0.860 | 376 | 1.00 | 0.944 | -0.322 | 0.022 |
| call | 267.5 | 12.20 | 14.65 | 10.79 | 0.803 | 35.00 | 2.00 | 0.905 | -0.485 | 0.034 |
| call | 270 | 9.75 | 12.30 | 8.47 | 0.730 | 455 | 8.00 | 0.873 | -0.545 | 0.041 |
| call | 272.5 | 7.60 | 10.00 | 7.67 | 0.658 | 139 | 30.00 | 0.796 | -0.773 | 0.056 |
| call | 275 | 5.15 | 7.75 | 6.45 | 0.584 | 463 | 31.00 | 0.738 | -0.785 | 0.065 |
| call | 277.5 | 3.65 | 4.80 | 4.40 | 0.422 | 216 | 91.00 | 0.650 | -0.790 | 0.074 |
| call | 280 | 2.44 | 2.95 | 2.89 | 0.393 | 792 | 2,325 | 0.526 | -0.762 | 0.079 |
| call | 282.5 | 1.20 | 2.09 | 1.59 | 0.382 | 621 | 591 | 0.394 | -0.799 | 0.076 |
| call | 285 | 0.63 | 0.93 | 0.95 | 0.331 | 1,100 | 196 | 0.270 | -0.667 | 0.066 |
| call | 287.5 | 0.18 | 0.40 | 0.35 | 0.312 | 318 | 47.00 | 0.159 | -0.462 | 0.048 |
| call | 290 | 0.11 | 0.22 | 0.18 | 0.337 | 1,095 | 369 | 0.105 | -0.372 | 0.036 |
| call | 292.5 | 0.06 | 0.30 | 0.07 | 0.400 | 767 | 84.00 | 0.095 | -0.413 | 0.034 |
| call | 295 | 0.00 | 0.06 | 0.06 | 0.357 | 622 | 34.00 | 0.047 | -0.227 | 0.020 |
| call | 297.5 | 0.00 | 0.36 | 0.03 | 0.406 | 25.00 | 9.00 | 0.045 | -0.249 | 0.019 |
| call | 300 | 0.02 | 0.12 | 0.01 | 0.454 | 134 | 7.00 | 0.035 | -0.220 | 0.015 |
| call | 302.5 | 0.00 | 0.68 | 0.38 | 0.501 | 3.00 | 0.00 | 0.023 | -0.157 | 0.011 |
| call | 305 | 0.00 | 0.67 | 0.04 | 0.547 | 41.00 | 0.00 | 0.020 | -0.147 | 0.009 |
| call | 307.5 | 0.00 | 0.67 | 0.01 | 0.592 | 6.00 | 0.00 | 0.016 | -0.129 | 0.008 |
| call | 310 | 0.00 | 0.67 | 0.01 | 0.636 | 4.00 | 0.00 | 0.014 | -0.121 | 0.007 |
| call | 315 | 0.00 | 0.67 | 0.11 | 0.723 | 1.00 | 0.00 | 0.012 | -0.125 | 0.006 |
| call | 320 | 0.00 | 0.11 | 0.00 | 0.755 | 0.00 | 0.00 | 0.006 | -0.069 | 0.004 |
| call | 325 | 0.00 | 0.67 | 0.00 | 0.887 | 0.00 | 0.00 | 0.010 | -0.131 | 0.005 |
| call | 330 | 0.00 | 0.67 | 0.00 | 0.966 | 0.00 | 0.00 | 0.009 | -0.133 | 0.005 |
| call | 335 | 0.00 | 0.67 | 0.00 | 1.043 | 0.00 | 0.00 | 0.009 | -0.136 | 0.005 |
| call | 340 | 0.00 | 0.67 | 0.00 | 1.117 | 0.00 | 0.00 | 0.008 | -0.137 | 0.005 |
| call | 345 | 0.00 | 0.01 | 0.74 | 1.005 | 1.00 | 0.00 | 0.011 | -0.127 | 0.007 |
| put | 140 | 0.00 | 0.92 | 0.14 | 3.119 | 2.00 | 0.00 | -0.001 | -0.034 | 0.000 |
| put | 145 | 0.00 | 0.92 | 0.01 | 2.969 | 16.00 | 2.00 | -0.001 | -0.034 | 0.000 |
| put | 150 | 0.00 | 0.75 | 0.01 | 2.824 | 7.00 | 0.00 | -0.001 | -0.034 | 0.000 |
| put | 155 | 0.00 | 0.92 | 0.08 | 2.684 | 11.00 | 0.00 | -0.001 | -0.034 | 0.000 |
| put | 160 | 0.00 | 0.92 | 0.09 | 2.549 | 11.00 | 0.00 | -0.001 | -0.033 | 0.000 |
| put | 165 | 0.00 | 0.92 | 0.01 | 2.417 | 14.00 | 0.00 | -0.001 | -0.033 | 0.001 |
| put | 170 | 0.00 | 0.01 | 0.08 | 1.857 | 26.00 | 0.00 | -0.001 | -0.022 | 0.001 |
| put | 175 | 0.00 | 0.75 | 0.09 | 2.164 | 6.00 | 0.00 | -0.001 | -0.033 | 0.001 |
| put | 180 | 0.00 | 0.67 | 0.08 | 2.042 | 6.00 | 0.00 | -0.001 | -0.033 | 0.001 |
| put | 185 | 0.00 | 0.67 | 0.08 | 1.924 | 8.00 | 0.00 | -0.001 | -0.032 | 0.001 |
| put | 190 | 0.00 | 0.02 | 0.08 | 1.673 | 5.00 | 0.00 | -0.003 | -0.069 | 0.002 |
| put | 195 | 0.00 | 0.01 | 0.01 | 1.571 | 7.00 | 0.00 | -0.003 | -0.068 | 0.002 |
| put | 200 | 0.00 | 0.92 | 0.02 | 1.586 | 2.00 | 0.00 | -0.001 | -0.032 | 0.001 |
| put | 205 | 0.00 | 0.92 | 0.10 | 1.478 | 1.00 | 0.00 | -0.001 | -0.031 | 0.001 |
| put | 210 | 0.00 | 0.01 | 0.01 | 1.334 | 3.00 | 2.00 | -0.002 | -0.049 | 0.002 |
| put | 215 | 0.00 | 0.02 | 0.01 | 1.269 | 45.00 | 3.00 | -0.001 | -0.031 | 0.001 |
| put | 220 | 0.00 | 0.92 | 0.06 | 1.167 | 55.00 | 0.00 | -0.001 | -0.030 | 0.001 |
| put | 225 | 0.00 | 0.75 | 0.01 | 1.067 | 114 | 0.00 | -0.002 | -0.030 | 0.001 |
| put | 230 | 0.00 | 0.02 | 0.01 | 0.969 | 65.00 | 4.00 | -0.002 | -0.030 | 0.001 |
| put | 232.5 | 0.00 | 0.67 | 0.00 | 0.985 | 0.00 | 0.00 | -0.003 | -0.053 | 0.002 |
| put | 235 | 0.00 | 0.67 | 0.01 | 0.933 | 176 | 1.00 | -0.003 | -0.053 | 0.002 |
| put | 237.5 | 0.00 | 0.67 | 0.12 | 0.883 | 3.00 | 0.00 | -0.004 | -0.052 | 0.002 |
| put | 240 | 0.00 | 0.02 | 0.01 | 0.832 | 348 | 8.00 | -0.004 | -0.052 | 0.002 |
| put | 242.5 | 0.00 | 0.67 | 0.15 | 0.818 | 14.00 | 0.00 | -0.006 | -0.072 | 0.003 |
| put | 245 | 0.00 | 0.67 | 0.69 | 0.766 | 182 | 0.00 | -0.006 | -0.071 | 0.003 |
| put | 247.5 | 0.00 | 0.67 | 0.14 | 0.714 | 8.00 | 0.00 | -0.006 | -0.070 | 0.004 |
| put | 250 | 0.00 | 0.20 | 0.01 | 0.663 | 189 | 104 | -0.007 | -0.069 | 0.004 |
| put | 252.5 | 0.00 | 0.68 | 0.14 | 0.612 | 115 | 0.00 | -0.008 | -0.070 | 0.004 |
| put | 255 | 0.01 | 0.03 | 0.01 | 0.560 | 243 | 102 | -0.012 | -0.097 | 0.006 |
| put | 257.5 | 0.00 | 0.05 | 0.03 | 0.544 | 365 | 10.00 | -0.022 | -0.173 | 0.011 |
| put | 260 | 0.00 | 0.06 | 0.02 | 0.503 | 474 | 103 | -0.033 | -0.231 | 0.015 |
| put | 262.5 | 0.00 | 0.14 | 0.04 | 0.459 | 178 | 119 | -0.044 | -0.279 | 0.019 |
| put | 265 | 0.01 | 0.07 | 0.05 | 0.402 | 498 | 2,200 | -0.056 | -0.307 | 0.022 |
| put | 267.5 | 0.02 | 0.17 | 0.07 | 0.406 | 235 | 2,402 | -0.095 | -0.470 | 0.034 |
| put | 270 | 0.05 | 0.20 | 0.16 | 0.353 | 303 | 159 | -0.127 | -0.529 | 0.041 |
| put | 272.5 | 0.05 | 0.67 | 0.48 | 0.404 | 256 | 109 | -0.204 | -0.758 | 0.056 |
| put | 275 | 0.39 | 0.80 | 0.55 | 0.340 | 239 | 68.00 | -0.262 | -0.769 | 0.065 |
| put | 277.5 | 0.56 | 1.65 | 1.28 | 0.362 | 89.00 | 31.00 | -0.350 | -0.774 | 0.074 |
| put | 280 | 1.69 | 2.25 | 2.00 | 0.306 | 108 | 50.00 | -0.474 | -0.745 | 0.079 |
| put | 282.5 | 2.78 | 4.20 | 3.38 | 0.378 | 25.00 | 10.00 | -0.606 | -0.783 | 0.076 |
| put | 285 | 3.60 | 6.20 | 4.55 | 0.424 | 7.00 | 3.00 | -0.730 | -0.650 | 0.066 |
| put | 287.5 | 5.70 | 8.05 | 10.20 | 0.415 | 20.00 | 1.00 | -0.841 | -0.445 | 0.048 |
| put | 290 | 8.50 | 10.35 | 0.00 | 0.458 | 0.00 | 0.00 | -0.895 | -0.355 | 0.036 |
| put | 292.5 | 10.40 | 13.05 | 0.00 | 0.578 | 0.00 | 0.00 | -0.905 | -0.395 | 0.034 |
| put | 295 | 12.80 | 15.50 | 0.00 | 0.642 | 0.00 | 0.00 | -0.953 | -0.209 | 0.020 |
| put | 297.5 | 15.45 | 18.50 | 0.00 | 0.824 | 0.00 | 0.00 | -0.955 | -0.231 | 0.019 |
| put | 300 | 18.00 | 21.05 | 20.68 | 0.910 | 1.00 | 1.00 | -0.965 | -0.202 | 0.015 |
| put | 302.5 | 20.35 | 22.80 | 0.00 | 0.793 | 0.00 | 0.00 | -0.977 | -0.138 | 0.011 |
| put | 305 | 22.90 | 25.55 | 0.00 | 0.929 | 0.00 | 0.00 | -0.980 | -0.128 | 0.009 |
| put | 307.5 | 25.35 | 28.50 | 27.30 | 1.110 | 1.00 | 0.00 | -0.984 | -0.109 | 0.008 |
| put | 310 | 27.90 | 30.55 | 0.00 | 1.056 | 0.00 | 0.00 | -0.986 | -0.101 | 0.007 |
| put | 315 | 32.85 | 35.50 | 51.20 | 1.162 | 0.00 | 0.00 | -0.988 | -0.104 | 0.006 |
| put | 320 | 37.85 | 41.10 | 0.00 | 1.457 | 0.00 | 0.00 | -0.989 | -0.107 | 0.006 |
| put | 325 | 42.90 | 46.20 | 0.00 | 1.606 | 0.00 | 0.00 | -0.990 | -0.109 | 0.005 |
| put | 330 | 47.95 | 50.50 | 0.00 | 1.498 | 0.00 | 0.00 | -0.990 | -0.111 | 0.005 |
| put | 335 | 52.65 | 56.10 | 0.00 | 1.808 | 0.00 | 0.00 | -0.991 | -0.113 | 0.005 |
| put | 340 | 57.65 | 61.00 | 62.20 | 1.886 | 0.00 | 2.00 | -0.992 | -0.114 | 0.005 |
| put | 345 | 62.95 | 66.00 | 67.20 | 1.991 | 0.00 | 2.00 | -0.998 | -0.007 | 0.001 |
Latest SEC filings
30| Filed | Form | Description | Period | Link |
|---|---|---|---|---|
| 2026-10-26 | 13F-HR | Further understand that each of 13F-HR, 13F-NT, and amendments thereto are mandatory electronic filings (hardship exemption exists to submit in paper; never used to the knowledge of IM staff); | 2026-09-30 | SEC |
| 2026-10-21 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) | 2026-09-27 | SEC |
| 2026-10-13 | 8-K | Current report | 2026-10-13 | SEC |
| 2026-09-10 | 4 | Statement of changes in beneficial ownership of securities | 2026-09-08 | SEC |
| 2026-09-10 | 4 | Statement of changes in beneficial ownership of securities | 2026-09-08 | SEC |
| 2026-09-10 | 4 | Statement of changes in beneficial ownership of securities | 2026-09-08 | SEC |
| 2026-09-04 | 4 | Statement of changes in beneficial ownership of securities | 2026-09-02 | SEC |
| 2026-09-02 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-09-01 | 3 | Initial statement of beneficial ownership of securities | 2026-09-01 | SEC |
| 2026-08-18 | 4 | Statement of changes in beneficial ownership of securities | 2026-08-17 | SEC |
| 2026-08-17 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-08-14 | 4 | Statement of changes in beneficial ownership of securities | 2026-08-13 | SEC |
| 2026-08-13 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-08-11 | N-PX | Annual Report of Proxy Voting Record of Registered Management Investment Companies filed on Form N-PX | 2026-06-30 | SEC |
| 2026-08-07 | 4 | Statement of changes in beneficial ownership of securities | 2026-08-05 | SEC |
| 2026-08-07 | 4 | Statement of changes in beneficial ownership of securities | 2026-08-06 | SEC |
| 2026-08-06 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-08-06 | 13F-HR | Further understand that each of 13F-HR, 13F-NT, and amendments thereto are mandatory electronic filings (hardship exemption exists to submit in paper; never used to the knowledge of IM staff); | 2026-06-30 | SEC |
| 2026-08-05 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-08-04 | 8-K | Current report | 2026-08-04 | SEC |
| 2026-07-29 | 8-K | Current report | 2026-07-29 | SEC |
| 2026-07-28 | 8-K | Current report | 2026-07-27 | SEC |
| 2026-07-23 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) | 2026-06-28 | SEC |
| 2026-07-21 | 4 | Statement of changes in beneficial ownership of securities | 2026-07-20 | SEC |
| 2026-07-20 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-07-15 | 8-K | Current report | 2026-07-15 | SEC |
| 2026-06-25 | 11-K | Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d) | 2025-12-31 | SEC |
| 2026-06-25 | 11-K | Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d) | 2025-12-31 | SEC |
| 2026-06-12 | 4 | Statement of changes in beneficial ownership of securities | 2026-06-11 | SEC |
| 2026-06-11 | 144 | Filing for proposed sale of securities under Rule 144. | SEC |
Insider activity by month
| Month | Bought | Buys | Sold | Sells |
|---|---|---|---|---|
| 2026-11 | 0 | 0 | 0 | 0 |
| 2026-10 | 0 | 0 | 0 | 0 |
| 2026-09 | 0 | 0 | 9.23M | 1 |
| 2026-08 | 0 | 0 | 52.76M | 4 |
| 2026-07 | 0 | 0 | 5.79M | 1 |
| 2026-06 | 0 | 0 | 2.41M | 1 |
| 2026-05 | 0 | 0 | 0 | 0 |
| 2026-04 | 0 | 0 | 0 | 0 |
| 2026-03 | 0 | 0 | 0 | 0 |
| 2026-02 | 0 | 0 | 58.35M | 8 |
| 2026-01 | 0 | 0 | 22.12M | 1 |
| 2025-12 | 0 | 0 | 0 | 0 |
| 2025-11 | 257.69K | 1 | 0 | 0 |
Institutional holders
| Manager | % owned |
|---|---|
| BlackRock, Inc. | 8.81% |
| VANGUARD CAPITAL MANAGEMENT LLC | 6.53% |
| STATE STREET CORP | 5.56% |
| GEODE CAPITAL MANAGEMENT, LLC | 2.72% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 2.67% |
| JPMORGAN CHASE & CO | 2.42% |
| MORGAN STANLEY | 1.86% |
| NORGES BANK | 1.32% |
| STATE FARM MUTUAL AUTOMOBILE INSURANCE CO | 1.31% |
| NORTHERN TRUST CORP | 1.20% |
Funds
| Fund | % owned |
|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND | 3.17% |
| VANGUARD 500 INDEX FUND | 2.59% |
| DFA TWO-YEAR GLOBAL FIXED INCOME PORTFOLIO | 1.87% |
| BBH Limited Duration Fund | 1.59% |
| First Eagle Overseas Fund | 1.45% |
| First Eagle Global Fund | 1.45% |
| iShares Core S&P 500 ETF | 1.38% |
| Fidelity 500 Index Fund | 1.30% |
| VANGUARD SHORT-TERM CORPORATE BOND INDEX FUND | 1.27% |
| Goldman Sachs Tactical Tilt Overlay Fund | 1.25% |
OakChart. JNJ. Cached 15 minutes.